跳至主要内容
临床试验/ISRCTN17105027
ISRCTN17105027已完成未知

Predicting vasovagal and other adverse events in Australian voluntary blood donors using a portable sensor that measures bio-signal data (PREVENT)

Australian Red Cross Lifeblood0 个研究点目标入组 522 人开始时间: 2021年12月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
522

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Eligible to donate as per the Australian Red Cross Lifeblood Guidelines for the Selection of Blood Donors
  • 2. Donating whole blood or plasma for the first time
  • 3. Willing and able to provide informed consent
  • 4. Has a plasma or whole blood appointment at one of the participating donor centres (appointment made as a walk-in donor or scheduled appointment)

排除标准

  • 1. Unwilling or unable to provide informed consent
  • 2. Lack of understanding of the English language necessary to complete questionnaires. This study will not use translation services or interpreters
  • 3. Contacted for a research study in the last 6 months as per Lifeblood contact policy
  • 4. Donors with therapeutic, autologous, sample or platelet donation appointments
  • 5. Lifeblood employees

研究者

相似试验